PERSIAN trial: Early results from a randomized phase II trial testing apalutamide and stereotactic body radiation therapy for low-burden, metastatic, hormone-sensitive prostate cancer. This is an ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results